Latest filing published 27 Aug 2018 for ReShape Lifesciences Inc., €87k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +120.2%Entry US$17.39 · Close at T+365 US$38.31
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kelly Huang: trading record in brief
Kelly Huang has filed trades across 2 companies (mainly through SEC (Form 4)), most often in ReShape Lifesciences Inc. and Precigen, Inc. Between 9 May 2014 and 23 August 2018, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €36k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
Most recently, on 27 August 2018, the filings show a share grant worth €87k in ReShape Lifesciences Inc. The latest purchase dates back some time: it was published 4,563 days ago, on 13 May 2014. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kelly Huang
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 54,945 shares@ US$1.82100.0% of flowCommon StockSEC:0001214659-18-005742:0
- 65,000 shares0Common Stock (Restricted Stock Award)SEC:0001214659-18-003874:0
- 3,200 shares@ US$15.78Common StockSEC:0001498902-14-000056:0Canonical exit: 7 Aug 2014 (T+90)
3 of 3 declarations
